Camp Denali, located at the 89-mile marker in Denali National Park, will reopen on June 2. The family-owned and operated lodge since 1952 has announced its 2023 summer speaker series, wildlife ...
Partner Sanofi has commenced dosing in a Phase 2 clinical trial of SAR443820 (DNL788) in individuals with amyotrophic lateral sclerosis (ALS) Denali to receive a milestone payment of $40 million from ...
Denali Therapeutics Inc (NASDAQ:DNLI) shares are moving lower in Thursday’s after-hours session after the company announced that its Phase 2 study of oditrasertib was discontinued. In the company’s ...
Zentalis Pharmaceuticals, Inc. announced that the first patient has been dosed in Part 2A of the DENALI Phase 2 clinical trial, which evaluates the efficacy of azenosertib for patients with Cyclin E1+ ...
SAN DIEGO, April 28, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results